| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 26, 2022 | Buy(P) | 10K | $0.18 | $2K | 293K |
| May 26, 2022 | Buy(P) | 11K | $0.18 | $2K | 304K |
| May 26, 2022 | Buy(P) | 3K | $0.18 | $612 | 263K |
| May 26, 2022 | Buy(P) | 19K | $0.18 | $3K | 282K |
| May 26, 2022 | Buy(P) | 708 | $0.18 | $127 | 282K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001615219-22-000087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Salarius Pharmaceuticals, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001615219-22-000087"
Use Arkolith to summarize insider buying and selling at Salarius Pharmaceuticals, Inc. over the last 90 days and cite the filings.